Medical Devices APAC

APAC Hearing Aids (OTC) Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Hearing Aids (OTC) Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $336.0 Mn Placeholder estimate
Estimate 2025 $379.3 Mn 21.6% of the global market
Projected 2034 $1.13 Bn 198% Adds $751.2 Mn over 9 forecast years
CAGR 2025–2034 12.9% Faster than 70% of 173 Medical Devices markets here
Key players 6 +1
  • APAC is 21.6% of the global market.
  • Among regions, the largest is North America at $766.4 Mn.
  • Fastest growing: Africa at 13.6% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$751.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hearing Aids (OTC) Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $336.0 Mn — —
2025 (base) $379.3 Mn +$43.3 Mn —
2026 (forecast) $428.3 Mn +$48.9 Mn +12.9%
2027 (forecast) $483.5 Mn +$55.2 Mn +27.5%
2028 (forecast) $545.9 Mn +$62.4 Mn +43.9%
2029 (forecast) $616.3 Mn +$70.4 Mn +62.5%
2030 (forecast) $695.8 Mn +$79.5 Mn +83.4%
2031 (forecast) $785.6 Mn +$89.8 Mn +107.1%
2032 (forecast) $886.9 Mn +$101.3 Mn +133.8%
2033 (forecast) $1.00 Bn +$114.4 Mn +164%
2034 (forecast) $1.13 Bn +$129.2 Mn +198%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.76 Bn
  2. North America $766.4 Mn
  3. US $708.4 Mn
  4. APAC (this report) $379.3 Mn
  5. Europe $276.6 Mn
  6. Canada $157.3 Mn
  7. China $155.1 Mn
  8. Japan $107.6 Mn
  9. Latin America $78.9 Mn
  10. Middle East $76.9 Mn
  11. Germany $65.6 Mn
  12. Italy $45.9 Mn
  13. France $42.6 Mn
  14. UK $38.3 Mn
  15. Brazil $39.2 Mn
  16. Spain $36.5 Mn
  17. India $35.4 Mn
  18. Ecuador $33.3 Mn
  19. Saudi Arabia $30.7 Mn
  20. Africa $29.9 Mn
  21. Mexico $23.0 Mn
  22. Australia $19.9 Mn
  23. Russia $19.4 Mn
  24. New Zealand $17.8 Mn
  25. South Africa $10.7 Mn
  26. UAE $8.5 Mn
  27. Egypt $5.4 Mn
  28. Philippines $3.9 Mn
  29. Hong Kong $3.1 Mn
  30. Malaysia $2.7 Mn
  31. Thailand $2.1 Mn
  32. Singapore $2.0 Mn
  33. Kenya $1.2 Mn

Report snapshot

APAC Hearing Aids (OTC) Market Analysis at a glance
Market size, 2025$379.3 Mn placeholder estimate
Forecast, 2034$1.13 Bn placeholder estimate
Growth (CAGR), 2025–203412.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and channel (see all)
Key playersSonova Holding AG, WS Audiology, GN Store Nord, Eargo, Apple Inc. and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Hearing Aids (OTC) Market Analysis Executive Summary

Over-the-counter hearing aids are sold directly to adults with mild to moderate hearing loss, without a prescription or fitting by a specialist.

Key segments of the hearing Aids (OTC) market include product (Behind-the-Ear, In-the-Ear and Earbud-Style) and channel (Retail Pharmacies, Online and Electronics Stores).

Bar chart: Asia Pacific Hearing Aids (OTC) market size, 2024–2034, placeholder estimates. $336.0 Mn in 2024, $379.3 Mn in 2025 and $1.13 Bn in 2034, 12.9% CAGR.
Asia Pacific Hearing Aids (OTC) market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Hearing Aids (OTC) Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hearing Aids (OTC) market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the hearing Aids (OTC) market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the hearing Aids (OTC) market.

Competitive Landscape for Hearing Aids (OTC) Market in APAC

The hearing Aids (OTC) market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hearing Aids (OTC) Market in APAC

Hearing Aids (OTC) in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[11], basic medical insurance (China)⁠[12], the Hospital Authority (Hong Kong)⁠[13], Ayushman Bharat PM-JAY (India)⁠[14], public health insurance (Japan)⁠[15], subsidised public care (Malaysia)⁠[16], Pharmac (New Zealand)⁠[17], PhilHealth (Philippines)⁠[18], MediShield Life (Singapore)⁠[19] and the Universal Coverage Scheme (Thailand)⁠[20].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[12] National Healthcare Security Administration. Checked 14 Nov 2026.

[13] Hospital Authority. Checked 14 Nov 2026.

[14] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[15] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[16] Ministry of Health Malaysia. Checked 14 Nov 2026.

[17] Pharmac. Checked 14 Nov 2026.

[18] PhilHealth. Checked 14 Nov 2026.

[19] CPF Board, MediShield Life. Checked 14 Nov 2026.

[20] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hearing Aids (OTC) products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hearing Aids (OTC) right now, from free public sources.

Patients

People aged 65 and over, % of people (WHO)
CountryValueYear
Afghanistan2.42025
Australia18.12025
Bangladesh6.72025
China14.92025
Hong Kong23.72025
India7.42025
Indonesia7.52025
Japan30.02025
Malaysia8.02025
Myanmar7.52025
Nepal6.62025
New Zealand17.62025
Pakistan4.42025
Philippines5.72025
Singapore14.22025
Thailand16.02025
Compare every country on the Public Health Dashboard

Latest research 2,604 papers since 2021 (worldwide)

  1. Patient-Reported Hearing-Aid Use Patterns and Noisy-Room Communication Difficulty While Using Hearing Aids Among U.S. Adults Aged 45 Years or Older: Analyses of the 2019 and 2024 NHIS. Patient preference and adherence, 2026
  2. Hearing assistance technologies and social health among individuals with care and support needs: a scoping review. BMC geriatrics, 2026
  3. Trends in the timing of non-implantable bone-conduction hearing rehabilitation in children with microtia or aural atresia: A 14-year retrospective study. International journal of pediatric otorhinolaryngology, 2026
  4. Effect of social frailty on patient-reported hearing aid benefits among older adults in Japan: a per-protocol cohort study. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026
  5. Neuromodulatory effects of audio-proprio-phonatory reinforcement training on subjective tinnitus, a HD-EEG study protocol. PloS one, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hearing Aids (OTC) in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hearing Aids (OTC) market in Asia Pacific?
Placeholder estimate: about $379.3 Mn in 2025, rising to about $1.13 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hearing Aids (OTC) market in Asia Pacific growing?
Placeholder estimate: about 12.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hearing Aids (OTC) market report cover?
The report splits the market by product (Behind-the-Ear, In-the-Ear, Earbud-Style) and channel (Retail Pharmacies, Online, Electronics Stores).
Who are the key players in the Hearing Aids (OTC) market?
Key players include Sonova Holding AG, WS Audiology, GN Store Nord, Eargo, Apple Inc. and Sony Corporation.
What is driving the Hearing Aids (OTC) market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hearing Aids (OTC) market. Older adults and their families are spending more on staying active and independent.
How much research is published on Hearing Aids (OTC)?
PubMed lists 2,604 papers on Hearing Aids (OTC) added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Hearing Aids (OTC) in APAC? Our analysts can size it for your plan. Talk to us See the public data People aged 65 and over for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Collagen Supplements: Skin, Joints and Real EvidenceCollagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Back to Catalogue
Keep exploring

Related Medical Devices reports in APAC

See all
Same topic, other categories

Related on hearing and geriatric

See the topic